Mark Sheptoff Financial Planning LLC Boosts Holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Mark Sheptoff Financial Planning LLC boosted its stake in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 1.4% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 30,025 shares of the company’s stock after purchasing an additional 400 shares during the period. Ryan Specialty makes up approximately 1.0% of Mark Sheptoff Financial Planning LLC’s portfolio, making the stock its 21st biggest holding. Mark Sheptoff Financial Planning LLC’s holdings in Ryan Specialty were worth $1,926,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also modified their holdings of the stock. Rakuten Securities Inc. purchased a new position in Ryan Specialty in the 4th quarter valued at about $27,000. Principal Securities Inc. raised its holdings in shares of Ryan Specialty by 164.7% during the fourth quarter. Principal Securities Inc. now owns 667 shares of the company’s stock valued at $43,000 after acquiring an additional 415 shares during the last quarter. Quarry LP lifted its position in shares of Ryan Specialty by 109.3% in the third quarter. Quarry LP now owns 808 shares of the company’s stock valued at $54,000 after acquiring an additional 422 shares in the last quarter. Harvest Fund Management Co. Ltd acquired a new stake in shares of Ryan Specialty in the fourth quarter worth approximately $54,000. Finally, Loomis Sayles & Co. L P increased its position in shares of Ryan Specialty by 26.3% during the third quarter. Loomis Sayles & Co. L P now owns 1,373 shares of the company’s stock worth $91,000 after purchasing an additional 286 shares in the last quarter. Institutional investors and hedge funds own 84.82% of the company’s stock.

Ryan Specialty Trading Up 0.1 %

Shares of RYAN stock opened at $72.43 on Wednesday. Ryan Specialty Holdings, Inc. has a twelve month low of $48.48 and a twelve month high of $75.97. The company has a market capitalization of $18.97 billion, a price-to-earnings ratio of 104.97, a PEG ratio of 1.19 and a beta of 0.71. The firm has a 50-day moving average price of $68.39 and a 200 day moving average price of $68.13. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40.

Ryan Specialty (NYSE:RYAN) last posted its quarterly earnings results on Thursday, February 20th. The company reported $0.45 earnings per share for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.02). The company had revenue of $663.53 million for the quarter, compared to analysts’ expectations of $658.80 million. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. Research analysts forecast that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current fiscal year.

Ryan Specialty Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Tuesday, March 4th were paid a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 0.66%. The ex-dividend date of this dividend was Tuesday, March 4th. This is a positive change from Ryan Specialty’s previous quarterly dividend of $0.11. Ryan Specialty’s dividend payout ratio (DPR) is 69.57%.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the stock. Morgan Stanley assumed coverage on shares of Ryan Specialty in a research note on Thursday, December 5th. They set an “overweight” rating and a $90.00 price objective for the company. Royal Bank of Canada cut their price target on Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating for the company in a report on Friday, February 21st. Keefe, Bruyette & Woods dropped their target price on Ryan Specialty from $77.00 to $76.00 and set an “outperform” rating for the company in a report on Friday, February 21st. Wells Fargo & Company upped their price objective on shares of Ryan Specialty from $64.00 to $69.00 and gave the company an “equal weight” rating in a report on Friday, February 21st. Finally, UBS Group lifted their target price on shares of Ryan Specialty from $82.00 to $84.00 and gave the stock a “buy” rating in a research note on Wednesday, February 26th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, Ryan Specialty presently has an average rating of “Hold” and a consensus target price of $75.27.

Insider Buying and Selling

In other news, Director Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock in a transaction dated Wednesday, January 15th. The shares were sold at an average price of $65.99, for a total value of $2,309,650.00. Following the completion of the transaction, the director now directly owns 35,609 shares of the company’s stock, valued at approximately $2,349,837.91. The trade was a 49.57 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP Brendan Martin Mulshine sold 30,000 shares of the stock in a transaction dated Friday, March 14th. The stock was sold at an average price of $69.30, for a total transaction of $2,079,000.00. The disclosure for this sale can be found here. Over the last quarter, insiders sold 241,360 shares of company stock worth $16,006,428. Insiders own 11.10% of the company’s stock.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.